Technology | Ablation Systems | December 08, 2017

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada

Addition to Niobe system provides simple-to-interpret indicator of catheter tip-to-tissue contact

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada

December 7, 2017 — Stereotaxis Inc. announced it has received regulatory clearance from Health Canada for its e-Contact Module, which provides physicians with a simple-to-interpret indicator of catheter tip-to-tissue contact. The technology was launched in Europe in June and to date has been utilized in more than 1,300 robotic catheter ablation procedures.

The e-Contact Module is Stereotaxis’ latest technology designed to improve patient outcomes, reduce procedure times and advance automation. Eugene Crystal, M.D., director of arrhythmia services at Sunnybrook Health Sciences Centre in Toronto, and president elect of SCRN, performed the first procedures with the e-Contact module in North America during the week of November 20.

“The latest Stereotaxis innovation adds to the Niobe system’s inherent advantages by providing the ability to accurately determine catheter-to-tissue contact at the point of interest,” said Crystal. “This feature has the capability to further improve robotic magnetic navigation outcomes and efficiency in complex ablation procedures like AF [atrial fibrillation] and VT [ventricular tachycardia] by ensuring first-pass, complete, durable linear lesions.”

For more information: www.stereotaxis.com

Related Content

CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems | October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems | October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems | August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems | July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems | May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems | May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems | February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems | January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems | November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Medtronic, FIRE AND ICE trial, Arctic Front, cryoballoon catheter ablation, radiofrequency RF ablation, study results, Asia Pacific Heart Rhythm Society Scientific Sessions
News | Ablation Systems | October 17, 2016
Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon...
Overlay Init